🔍 RecallPedia

Nucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutaneous use only, Rx Only, Manufactured by GlaxoSmithKline LLC, Philadelphia, PA 19112, Distributed by GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0892-42.

Class I - Dangerous
💊 Drugs Recalled: September 6, 2019 Cardinal Health Prescription Drugs Nationwide

What Should You Do?

  1. Check if you have this product:
    Lot #: S25X, Exp. 03/31/21
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Cardinal Health dba Specialty Pharmaceutical Services
Reason for Recall:
Temperature Abuse; Product stored and shipped outside of labeled storage requirements.
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
terminated

Product Information

Full Description:

Nucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutaneous use only, Rx Only, Manufactured by GlaxoSmithKline LLC, Philadelphia, PA 19112, Distributed by GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0892-42.

Product Codes/Lot Numbers:

Lot #: S25X, Exp. 03/31/21

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-1876-2019

Related Recalls